Literature DB >> 3745972

A prospective study of the mechanisms of infection associated with hemodialysis catheters.

J S Cheesbrough, R G Finch, R P Burden.   

Abstract

Seventy-four subclavian hemodialysis catheters inserted into 53 patients were studied prospectively. Sixteen of 64 assessable catheterization periods were complicated by clinically documented catheter-related sepsis, and 13 had an associated bacteremia. One patient died from catheter-related sepsis, and in two others, sepsis contributed to death. Staphylococci accounted for 11 bacteremias. Semiquantitative culture of the catheters indicated that 28 were significantly colonized. Comparison of these isolates with skin cultures from the insertion site suggested that the origin of the colonizing organisms was the skin (10 cases), intralumenal contamination (16 cases), or both routes (2 cases). Comparison of cultures taken during catheter insertion with those at removal rarely suggested that organisms introduced at insertion caused subsequent colonization. This study has demonstrated that infectious complications from using subclavian hemodialysis catheters exceed reported rates for all other modes of vascular access used for hemodialysis, as well as other indications for central venous catheterization.

Entities:  

Mesh:

Year:  1986        PMID: 3745972     DOI: 10.1093/infdis/154.4.579

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Nosocomial Infections in the Intensive Care Unit Associated with Invasive Medical Devices.

Authors:  Nasia Safdar; Christopher J. Crnich; Dennis G. Maki
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

2.  Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies.

Authors:  R J Sherertz; S O Heard; I I Raad
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  The Role of Intravascular Devices in Sepsis.

Authors:  Christopher J. Crnich; Dennis G. Maki
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

4.  Skin versus hub cultures to predict colonization and infection of central venous catheter in intensive care patients.

Authors:  B Guidet; I Nicola; V Barakett; J M Gabillet; E Snoey; J C Petit; G Offenstadt
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

5.  Identification of a fibronectin-binding protein from Staphylococcus epidermidis.

Authors:  Rachel J Williams; Brian Henderson; Lindsay J Sharp; Sean P Nair
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 6.  Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci.

Authors:  M A Pfaller; L A Herwaldt
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

7.  Chlorhexidine-based antiseptic solutions effectively reduce catheter-related bacteremia.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Anthony Billings; Rosa Diaz; Denise Francoeur; Carolyn Abitbol; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2009-03-19       Impact factor: 3.714

8.  Incidence of catheter-associated gram-negative bacteremia in children with short bowel syndrome.

Authors:  P A Piedra; D M Dryja; L J LaScolea
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

9.  Central venous catheters as a vascular access modality for pediatric hemodialysis.

Authors:  Fatina Ibrahim Fadel; Hesham Nabil Abdel Mooty; Hafez Mahmoud Bazaraa; Samar Mohamed Sabry
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

10.  Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients.

Authors:  Jennifer K Broom; Stacey O'Shea; Sridevi Govindarajulu; E Geoffrey Playford; Carmel M Hawley; Nicole M Isbel; Scott B Campbell; David W Mudge; Sally Carpenter; Barbara C Johnson; Neil P Underwood; David W Johnson
Journal:  BMC Nephrol       Date:  2009-08-20       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.